Molecule Structure

Scientific Name

Sulbactam

Description of the Drug

Sulbactam is an beta-lactamase inhibitor antibiotic combined with other antibiotics to treat a variety of susceptible bacterial infections.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09324

Brand Name(s)

Not Available

Company Owner(s)

Wytells Pharma Private Ltd, Mylan Laboratories Ltd, Sandoz Inc, Pharmaceutical Associates Inc, Hospira Inc, Hq Specialty Pharma Corp, Pfizer Laboratories Div Pfizer Inc, Istituto Biochimico Italiano Spa, Acs Dobfar Spa, Hikma Pharmaceuticals Usa Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Bacterial beta-lactamase TEM SINGLE PROTEIN INHIBITOR CHEMBL2364670

Unichem Links

SureChEMBL SCHEMBL47781
DrugBank DB09324
PubChem: Thomson Pharma 15121712 14847263
PubChem 130313
Mcule MCULE-8384465258
LINCS LSM-5553
Nikkaji J689.013J J19.104C
PDBe 0RN
BindingDB 50021954
EPA CompTox Dashboard DTXSID1023605
DrugCentral 2492
Brenda 1420 105742
ChemicalBook CB1419201
Guide to Pharmacology 10769
rxnorm SULBACTAM SODIUM SULBACTAM
KEGG Ligand C07770
ChEBI 9321
ZINC ZINC000000897244